z-logo
open-access-imgOpen Access
CSF concentration of cefotaxime in adult patients with pneumococcal meningitis: a multicentre retrospective study
Author(s) -
Paul Le Turnier,
Najoua El Helali,
Romain Guilhaumou,
B. Pilmis,
Matthieu Revest,
Lionel Velly,
AnneGaëlle Leroy,
Xavier Duval,
F. Lemaı̂tre,
Matthieu Grégoire,
Anne-Gaëlle Leroy,
Najoua El-Helali,
Florian Lemaitre,
Jean–Philippe Talarmin,
JeanLuc Schmit,
Youssef Bennis,
Alexandre Charmillon,
Julien ScalaBertola,
Joy Mootien,
Solen Kernéis,
Firouzé BaniSadr,
Yohan N’Guyen,
Zoubir Djerada
Publication year - 2021
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkab191
Subject(s) - cefotaxime , streptococcus pneumoniae , medicine , meningitis , tolerability , gastroenterology , pneumococcal infections , antibiotics , surgery , microbiology and biotechnology , adverse effect , biology
Pneumococcal meningitis is a devastating disease that requires adequate meningeal antibiotic penetration to limit the mortality. Despite a large usage in this indication, data about CSF concentration of cefotaxime during pneumococcal meningitis in adults are scarce. Therefore, we aimed to describe the CSF concentration obtained after high-dose cefotaxime administration in adult patients treated for Streptococcus pneumoniae meningitis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom